Literature DB >> 35675796

Stroke Severity among Men and Women Acute Ischemic Stroke Patients in the Telestroke Network.

Nicolas Poupore1, Camron Edrissi1, Mareshah Sowah1, Madison Stanley1, Jonah Joffe1, Donovan Lewis1, Teanda Cunningham1, Carolyn Breauna Sanders1, Krista Knisely1, Chase Rathfoot1, Thomas I Nathaniel1.   

Abstract

INTRODUCTION: This study investigates gender differences among stroke patients treated in the telestroke network using specific risk factors that contribute to stroke severity.
METHODS: We examined gender differences in stroke severity among 454 patients hospitalized with acute ischemic stroke (AIS). The logistic regression model was used to predict clinical risk factors associated with stroke severity in men and women AIS patients.
RESULTS: In the adjusted analysis among women patients, increasing age (odds ratio [OR] = 1.05, 95% CI: 1.017-1.085, p = 0.003) and higher heart rate (OR = 1.031, 95% CI: 1.005-1.058, p = 0.021) were associated with worsening neurological functions, while direct admission (OR = 0.191, 95% CI: 0.079-0.465, p < 0.001) was associated with improving neurologic functions. Among men, hypertension (OR = 3.077, 95% CI: 1.060-8.931, p = 0.039) and higher international normalized ratio (INR) (OR = 21.959, 95% CI: 1.489-323.912, p = 0.024) were associated with worsening neurologic functions, while Caucasian (OR = 0.181, 95% CI: 0.062-0.526, p = 0.002) and obesity (OR = 0.449, 95% CI: 0.203-0.99, p = 0.047) were associated with neurologic improvement.
CONCLUSION: Increasing age and heart rate in women, hypertension and greater INR in men contribute to worsening neurologic functions. There is a need to develop strategies to improve the care of both men and women in the telestroke network.
© 2022 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Elderly patients; Ischemic stroke; Outcomes; Risk factors; Sex differences

Mesh:

Substances:

Year:  2022        PMID: 35675796      PMCID: PMC9574206          DOI: 10.1159/000525099

Source DB:  PubMed          Journal:  Cerebrovasc Dis Extra        ISSN: 1664-5456


  38 in total

1.  Clinical Risk Factors in Thrombolysis therapy: Telestroke Versus Nontelestroke.

Authors:  Thomas I Nathaniel; Jordan Gainey; Brice Blum; Chelsea Montgomery; Lowther Ervin; Lee Madeline
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-05-30       Impact factor: 2.136

Review 2.  Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis.

Authors:  Jamie L Banks; Charles A Marotta
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

3.  Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.

Authors:  T R Lawson; I E Brown; D L Westerkam; D W Blackhurst; S Sternberg; R Leacock; T I Nathaniel
Journal:  Restor Neurol Neurosci       Date:  2015       Impact factor: 2.406

4.  Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.

Authors:  Larry B Goldstein; Robert Adams; Mark J Alberts; Lawrence J Appel; Lawrence M Brass; Cheryl D Bushnell; Antonio Culebras; Thomas J Degraba; Philip B Gorelick; John R Guyton; Robert G Hart; George Howard; Margaret Kelly-Hayes; J V Ian Nixon; Ralph L Sacco
Journal:  Stroke       Date:  2006-05-04       Impact factor: 7.914

5.  Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke.

Authors:  Amelia K Boehme; James E Siegler; Michael T Mullen; Karen C Albright; Michael J Lyerly; Dominique J Monlezun; Erica M Jones; Rikki Tanner; Nicole R Gonzales; T Mark Beasley; James C Grotta; Sean I Savitz; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-01-25       Impact factor: 2.136

Review 6.  Body mass index and mortality in heart failure: a meta-analysis.

Authors:  Antigone Oreopoulos; Raj Padwal; Kamyar Kalantar-Zadeh; Gregg C Fonarow; Colleen M Norris; Finlay A McAlister
Journal:  Am Heart J       Date:  2008-07       Impact factor: 4.749

7.  Predictors of thrombolysis in the telestroke and non telestroke settings for hypertensive acute ischemic stroke patients.

Authors:  Leanne Brecthel; Jordan Gainey; Alexandria Penwell; Thomas I Nathaniel
Journal:  BMC Neurol       Date:  2018-12-21       Impact factor: 2.474

8.  Heterogeneity among women with stroke: health, demographic and healthcare utilization differentials.

Authors:  Molly M Jacobs; Charles Ellis
Journal:  BMC Womens Health       Date:  2021-04-17       Impact factor: 2.809

9.  Investigation of Gender Differences and Exclusive Criteria in a Diabetic Acute Ischemic Stroke Population Treated with Recombinant Tissue-Type Plasminogen Activator (rtPA).

Authors:  Taylor Wapshott; Brice Blum; Williams Kelsey; Thomas I Nathaniel
Journal:  J Vasc Interv Neurol       Date:  2017-12

10.  Functional Outcome Measures of Recombinant Tissue Plasminogen Activator-Treated Stroke Patients in the Telestroke Technology.

Authors:  Jordan Gainey; Leanne Brecthtel; Brice Blum; Aaliyah Keels; Lee Madeline; Ervin Lowther; Thomas Nathaniel
Journal:  J Exp Neurosci       Date:  2018-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.